Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

2.

Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.

Sadykov RR, Podmelle F, Sadykov RA, Kasimova KR, Metellmann HR.

Int J Oral Maxillofac Surg. 2013 Jul;42(7):863-7. doi: 10.1016/j.ijom.2013.03.015. Epub 2013 Apr 22.

PMID:
23618833
3.

A randomized controlled trial of propranolol for infantile hemangiomas.

Hogeling M, Adams S, Wargon O.

Pediatrics. 2011 Aug;128(2):e259-66. doi: 10.1542/peds.2010-0029. Epub 2011 Jul 25.

PMID:
21788220
4.

Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial.

Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, He J, Greene EA, Puttgen KB.

JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):323-30. doi: 10.1001/jamaoto.2013.6723.

PMID:
24526257
5.

Propranolol for infantile hemangiomas.

Bagazgoitia L, Torrelo A, Gutiérrez JC, Hernández-Martín A, Luna P, Gutiérrez M, Baño A, Tamariz A, Larralde M, Alvarez R, Pardo N, Baselga E.

Pediatr Dermatol. 2011 Mar-Apr;28(2):108-14. doi: 10.1111/j.1525-1470.2011.01345.x. Epub 2011 Mar 8.

PMID:
21385205
6.

Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.

Celik A, Tiryaki S, Musayev A, Kismali E, Levent E, Ergun O.

J Drugs Dermatol. 2012 Jul;11(7):808-11.

PMID:
22777220
7.

The role of propranolol in the treatment of infantile hemangioma.

Laranjo S, Costa G, Paramés F, Freitas I, Martins JD, Trigo C, Pinto FF.

Rev Port Cardiol. 2014 May;33(5):289-95. doi: 10.1016/j.repc.2013.10.018. Epub 2014 Jun 4.

PMID:
24906291
8.

The use of propranolol for complicated infantile hemangiomas.

Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P.

Int J Dermatol. 2013 Sep;52(9):1140-6. doi: 10.1111/j.1365-4632.2012.05795.x. Epub 2013 Jul 8.

PMID:
23829783
9.

Oral propranolol: an effective, safe treatment for infantile hemangiomas.

Zaher H, Rasheed H, Hegazy RA, Hegazy RA, Abdelhalim DM, Gawdat HI.

Eur J Dermatol. 2011 Jul-Aug;21(4):558-63. doi: 10.1684/ejd.2011.1372.

PMID:
21697036
10.

Propranolol and infantile hemangiomas four years later: a systematic review.

Marqueling AL, Oza V, Frieden IJ, Puttgen KB.

Pediatr Dermatol. 2013 Mar-Apr;30(2):182-91. doi: 10.1111/pde.12089. Epub 2013 Feb 14. Review.

PMID:
23405852
11.

Topical propranolol for treatment of superficial infantile hemangiomas.

Xu G, Lv R, Zhao Z, Huo R.

J Am Acad Dermatol. 2012 Dec;67(6):1210-3. doi: 10.1016/j.jaad.2012.03.009. Epub 2012 Apr 18.

PMID:
22516113
12.

Low-dose propranolol for infantile haemangioma.

Tan ST, Itinteang T, Leadbitter P.

J Plast Reconstr Aesthet Surg. 2011 Mar;64(3):292-9. doi: 10.1016/j.bjps.2010.06.010. Epub 2010 Jul 7.

PMID:
20615772
13.

Propranolol for infantile haemangioma: striking effect in the first weeks.

Katona G, Csákányi Z, Gács E, Szalai Z, Ráth G, Gerlinger I.

Int J Pediatr Otorhinolaryngol. 2012 Dec;76(12):1746-50. doi: 10.1016/j.ijporl.2012.08.014. Epub 2012 Sep 1.

PMID:
22944359
14.

Late rebound of infantile hemangioma after cessation of oral propranolol.

Shehata N, Powell J, Dubois J, Hatami A, Rousseau E, Ondrejchak S, McCuaig C.

Pediatr Dermatol. 2013 Sep-Oct;30(5):587-91. doi: 10.1111/pde.12190.

PMID:
24016283
15.

Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.

Zaher H, Rasheed H, Esmat S, Hegazy RA, Gawdat HI, Hegazy RA, El-Komy M, Abdelhalim DM.

Eur J Dermatol. 2013 Sep-Oct;23(5):646-52. doi: 10.1684/ejd.2013.2146.

PMID:
24135427
16.

[Treatment of superficial infantile hemangiomas with topical propranolol].

Niu JN, Xu GQ, Lü RR, Huo R.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2013 Mar;29(2):100-3. Chinese.

PMID:
23772486
17.

Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.

Kim KH, Choi TH, Choi Y, Park YW, Hong KY, Kim DY, Choe YS, Lee H, Cheon JE, Park JB, Park KD, Kang HJ, Shin HY, Jeong JH.

JAMA Dermatol. 2017 Jun 1;153(6):529-536. doi: 10.1001/jamadermatol.2017.0250.

PMID:
28423174
18.

Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.

Vivas-Colmenares GV, Bernabeu-Wittel J, Alonso-Arroyo V, Matute de Cardenas JA, Fernandez-Pineda I.

Pediatr Dermatol. 2015 May-Jun;32(3):348-52. doi: 10.1111/pde.12520. Epub 2015 Feb 26.

PMID:
25721095
19.

Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.

Sagi L, Zvulunov A, Lapidoth M, Ben Amitai D.

Dermatology. 2014;228(2):136-44. doi: 10.1159/000351557. Epub 2014 Feb 15.

PMID:
24556822
20.

Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.

MacIsaac ZM, Nayar HS, Gehris R, Mehta D, Geisler S, Grunwaldt LJ.

J Craniofac Surg. 2016 Jan;27(1):159-62. doi: 10.1097/SCS.0000000000002206.

PMID:
26674892

Supplemental Content

Support Center